Reported Reactions

Devices

Device brand name · Vidas brahms procalcitonin 60t

Vidas Brahms Procalcitonin 60t: medical device reports filed with FDA

154 reports name it, 2021–2022. Manufacturer given most often on reports: Biomerieux.

154
device reports naming the brand
0% of all MAUDE reports · about 28 a year
0
reports, 12 months to August 2026
0 in the 12 months before
99.4%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 154 reports that name the brand "Vidas Brahms Procalcitonin 60t" (vidas brahms procalcitonin 60t), received between February 2021 and March 2022; the manufacturer given most often on reports is Biomerieux. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.4%). Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are unable to obtain readings (90.3%), low test results (1.9%) and false negative result (1.3%). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

051101Sep 2021: 1Oct 2021: 4Nov 2021: 101Dec 2021: 392022Jan 2022: 0Feb 2022: 2Mar 2022: 1Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type, as classified on the report

Death0%0
Injury0%0
Malfunction99.4%153
Other0%0
Not given0.6%1

Who filed the report

Manufacturer report100%154
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShare
Unable to obtain readings13990.3%
Low test results31.9%
False negative result21.3%
High test results21.3%
Incorrect, inadequate or imprecise result or readings21.3%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

In context

MeasureVidas Brahms Procalcitonin 60tAll MAUDE reports
Reports15426,136,888
Share of that pool—0%
Classified as death, per 1,000 reports09
Classified as injury0%36.2%
Classified as malfunction99.4%62.3%
Filed by the manufacturer100%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Questions about Vidas Brahms Procalcitonin 60t reports

How many FDA reports name Vidas Brahms Procalcitonin 60t?

154 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (99.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

unable to obtain readings (90.3%), low test results (1.9%), false negative result (1.3%), high test results (1.3%) and incorrect, inadequate or imprecise result or readings (1.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Vidas Brahms Procalcitonin 60t was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.